Labcorp Holdings Inc. LH has agreed to acquire the prenatal health testing business of Myriad Genetics Inc. MYGN in an ...

The proposed deal follows closely behind Labcorp announcing a deal to acquire certain laboratory testing businesses from ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, and Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, ...

Labcorp has agreed to acquire select BioReference Health assets from OPKO Health in a transaction that includes $722 million ...

Labcorp and OPKO Health have partnered up for an agreement that sees Labcorp acquire select assets of BioReference Health, a ...

Labcorp will pick up specialty testing in women’s health as well as a blood test that assesses the likelihood of finding aggressive prostate cancer before a biopsy decision.

BURLINGTON, N.C.--(BUSINESS WIRE)--Nearly 10 million people in the United States have a history of systemic or anaphylactic reaction to insect stings, with the risk of a severe and potentially ...

New test supports public health preparedness efforts and testing infrastructure amid multistate outbreak of H5 bird flu in poultry and dairy cows BURLINGTON, N.C., Dec. 17, 2024 /PRNewswire/ -- ...

BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the launch of the first widely accessible test that provides direct evidence of ...

OPKO Health (OPK) stock jumps as Labcorp (LH) agrees to acquire a portfolio of assets held by its BioReference Health unit ...

Oct 15 (Reuters) - Laboratory operator Labcorp said on Thursday it will buy some assets from Opko Health's subsidiary in a ...